Comparative Proteomic Analysis Reveals Varying Impact on Immune Responses in Phorbol 12-Myristate-13-Acetate-Mediated THP-1 Monocyte-to-Macrophage Differentiation.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 19 03 2021
accepted: 25 05 2021
entrez: 8 7 2021
pubmed: 9 7 2021
medline: 30 10 2021
Statut: epublish

Résumé

Macrophages are sentinels of the innate immune system, and the human monocytic cell line THP-1 is one of the widely used

Identifiants

pubmed: 34234780
doi: 10.3389/fimmu.2021.679458
pmc: PMC8255674
doi:

Substances chimiques

Biomarkers 0
Cytokines 0
Inflammation Mediators 0
Proteome 0
Tetradecanoylphorbol Acetate NI40JAQ945

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

679458

Informations de copyright

Copyright © 2021 Pinto, Kim, Subbannayya, Giambelluca, Bösl, Ryan, Sharma and Kandasamy.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Trends Mol Med. 2007 Nov;13(11):460-9
pubmed: 18029230
J Cell Biol. 2018 Apr 2;217(4):1411-1429
pubmed: 29440514
Nat Methods. 2014 Mar;11(3):319-24
pubmed: 24487582
Cell Death Differ. 2007 Sep;14(9):1590-604
pubmed: 17599095
J Atheroscler Thromb. 2004;11(2):88-97
pubmed: 15153668
Sci China Life Sci. 2015 Dec;58(12):1282-7
pubmed: 26582014
Res Immunol. 1998 Sep-Oct;149(7-8):685-8
pubmed: 9851524
Mol Cell. 2002 Aug;10(2):417-26
pubmed: 12191486
Leuk Res. 1992;16(3):317-27
pubmed: 1532844
Front Immunol. 2014 Oct 07;5:491
pubmed: 25339958
Nucleic Acids Res. 2016 Jan 4;44(D1):D447-56
pubmed: 26527722
Mol Cell Proteomics. 2017 May;16(5):770-785
pubmed: 28336715
Science. 2002 Dec 6;298(5600):1912-34
pubmed: 12471243
Cytotechnology. 1991 Jan;5(Suppl 2):75-93
pubmed: 22359047
Cancer Res. 1982 Apr;42(4):1530-6
pubmed: 6949641
Mol Cancer. 2014 Feb 20;13:31
pubmed: 24555568
PLoS One. 2018 Mar 14;13(3):e0193601
pubmed: 29538403
Biochem Biophys Res Commun. 1995 Apr 6;209(1):60-5
pubmed: 7726865
Front Cell Dev Biol. 2016 Mar 30;4:21
pubmed: 27066479
Inflamm Res. 2007 Jan;56(1):45-50
pubmed: 17334670
Cell Res. 2011 Jan;21(1):71-85
pubmed: 21173796
Int J Mol Sci. 2019 Apr 27;20(9):
pubmed: 31035605
Arterioscler Thromb Vasc Biol. 1998 Oct;18(10):1589-99
pubmed: 9763531
Nat Immunol. 2017 May;18(5):583-593
pubmed: 28263321
Nat Protoc. 2009;4(4):484-94
pubmed: 19300442
Int J Mol Sci. 2019 Jun 02;20(11):
pubmed: 31159473
J Leukoc Biol. 2000 Jan;67(1):97-103
pubmed: 10648003
Cell Immunol. 2018 Oct;332:58-76
pubmed: 30077333
Exp Cell Res. 2004 Jul 1;297(1):68-81
pubmed: 15194426
Am J Reprod Immunol. 2013 Jul;70(1):80-6
pubmed: 23621670
Immunology. 1997 Dec;92(4):519-26
pubmed: 9497494
Int Immunopharmacol. 2014 Nov;23(1):37-45
pubmed: 25130606
Cell. 2002 Jan 25;108(2):233-46
pubmed: 11832213
PLoS Pathog. 2010 Feb 26;6(2):e1000661
pubmed: 20195505
Nanomaterials (Basel). 2017 Oct 17;7(10):
pubmed: 29039753
J Leukoc Biol. 1996 Apr;59(4):555-61
pubmed: 8613704
Experientia. 1991 Jan 15;47(1):22-31
pubmed: 1999239
J Mass Spectrom. 2003 May;38(5):523-5
pubmed: 12794873
J Leukoc Biol. 2007 Sep;82(3):710-20
pubmed: 17595377
Biol Reprod. 2017 Sep 1;97(3):400-412
pubmed: 29025069
J Cell Sci Suppl. 1986;4:267-86
pubmed: 3528195
PLoS One. 2010 Jan 13;5(1):e8668
pubmed: 20084270
Blood. 1989 Nov 15;74(7):2527-34
pubmed: 2478233
Immunity. 2003 Jul;19(1):2-4
pubmed: 12871633
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Infect Immun. 2005 May;73(5):2835-40
pubmed: 15845488
Front Pharmacol. 2018 Feb 22;9:71
pubmed: 29520230
Immunology. 1992 May;76(1):65-71
pubmed: 1628903
J Immunol Methods. 2016 Mar;430:64-70
pubmed: 26826276
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Atherosclerosis. 2012 Mar;221(1):2-11
pubmed: 21978918
Cell. 2014 May 22;157(5):1013-22
pubmed: 24855941
Eur J Immunol. 1993 Sep;23(9):2053-8
pubmed: 7690321
F1000Prime Rep. 2014 Nov 04;6:97
pubmed: 25580251
Biomed Pharmacother. 1994;48(10):445-53
pubmed: 7858154
J Leukoc Biol. 2000 May;67(5):699-704
pubmed: 10811011
Nat Rev Immunol. 2005 Dec;5(12):953-64
pubmed: 16322748
Mol Cell Proteomics. 2017 Dec;16(12):2153-2168
pubmed: 28887380
Nature. 2011 Jan 13;469(7329):221-5
pubmed: 21124315
Immunobiology. 2011 Aug;216(8):882-90
pubmed: 21458881

Auteurs

Sneha M Pinto (SM)

Centre of Molecular Inflammation Research (CEMIR), and Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
Center for Systems Biology and Molecular Medicine, Yenepoya (Deemed to be University), Mangalore, India.

Hera Kim (H)

Centre of Molecular Inflammation Research (CEMIR), and Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.

Yashwanth Subbannayya (Y)

Centre of Molecular Inflammation Research (CEMIR), and Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.

Miriam S Giambelluca (MS)

Centre of Molecular Inflammation Research (CEMIR), and Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.

Korbinian Bösl (K)

Centre of Molecular Inflammation Research (CEMIR), and Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
Department of Infectious Diseases, Medical Clinic, St. Olavs Hospital, Trondheim, Norway.

Liv Ryan (L)

Centre of Molecular Inflammation Research (CEMIR), and Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.

Animesh Sharma (A)

Proteomics and Modomics Experimental Core, PROMEC, Norwegian University of Science and Technology and the Central Norway Regional Health Authority, Stjørdal, Norway.

Richard K Kandasamy (RK)

Centre of Molecular Inflammation Research (CEMIR), and Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH